Project- Clinical impact and cost-effectiveness of a wireless vital signs monitor
Assumpta's project examines the clinical impact and cost-effectiveness of a wearable vital signs monitoring system, neoGuard, for critically ill newborns in Kenya where the newborn mortality rate is one of the highest in the world. With the neoGuard technology, nurses and clinicians can attach wireless wearable devices on up to 15 patients at a time and conveniently monitor their clinical status from a central dashboard hosted on a tablet. The health staff will receive real-time audio and visual alerts immediately a patient's vital signs exceed the preset upper or lower limits. This allows for more timely and effective interventions, giving newborns the best chance to survive and thrive.